BIOT
Instinct Bio Technical Company Holdings Inc. · NASDAQ
- Market cap
- $5.4M
Instinct Bio Technical Company Holdings Inc. (BIOT) is a Package Goods/Cosmetics company listed on NASDAQ. In the last 30 days Quantisnow tracked 2 wire items for BIOT, including 1 SEC filing and 1 13D/G filing. The most recent was published Nov 10, 2026.
News · 26 weeks16-50%
2026-05-242026-11-15
Mix690d
- SEC Filings4(67%)
- Other1(17%)
- 13D/G1(17%)
Activity · 52 weeks1915 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- 13D/GSEC Form SCHEDULE 13G filed by Instinct Bio Technical Company Holdings Inc.SCHEDULE 13G - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Subject)
- SECSEC Form 6-K filed by Biotech Acquisition Company6-K - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- SECSEC Form 6-K filed by Biotech Acquisition Company6-K - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- SECSEC Form 6-K filed by Biotech Acquisition Company6-K - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- SECSEC Form 6-K filed by Biotech Acquisition Company6-K - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- PRINSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development InitiativesNEW YORK and TOKYO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (NASDAQ:BIOT) ("Instinct Bio" or the "Company") today provided an operational update on the initiatives previously announced on July 29, July 30 and August 10, 2026, relating to its GENRÊVER CLINIC platform in Indonesia and its product development collaborations with Invitrx Therapeutics, Inc. ("INVITRX") and PT PARVA CANDELA ("PARVA"). Operational Highlights The Company has secured a 213 m² premises in the Gandaria district of South Jakarta for its first planned GENRÊVER CLINIC site, and interior construction activities have commenced. Subject to construction progress, permitting, and ope
- SECSEC Form 6-K filed by Biotech Acquisition Company6-K - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- PRInstinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in IndonesiaNEW YORK and TOKYO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (NASDAQ:BIOT) ("Instinct Bio" or the "Company") today announced a cooperation agreement with PT PARVA CANDELA ("PARVA"), an Indonesian cosmetics manufacturer and distributor, to jointly develop Indonesia’s cosmetics and personal care market under a "Made in Indonesia, Powered by Japanese Formulation Expertise" concept. Key Facts Route to market: PARVA is affiliated with DELTASPA Group, a spa chain operating approximately 25 locations across Indonesia, providing an established distribution network from day one.Proven sales playbook: Products from PARVA’s facility will be sold using the B2B a
- SECSEC Form 6-K filed by Biotech Acquisition Company6-K - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- SECSEC Form 6-K filed by Biotech Acquisition Company6-K - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- PRBIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics MarketsNEW YORK and TOKYO, July 29, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (NASDAQ:BIOT) ("Instinct Bio" or the "Company") today announced its decision to bring its own Japanese aesthetic healthcare brand "GENRÊVER CLINIC" to Indonesia and, together with a local Indonesian physician, to launch a subscription-model membership beauty clinic business. The proposed business model is expected to offer customers a flat-fee membership structure with flexible cancellation terms. The Company believes that this subscription-based membership model represents a differentiated offering in the Indonesian aesthetic clinic market. The Company intends to explore opportunities in Ind
- SECSEC Form 20-F filed by Biotech Acquisition Company20-F - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- SECSEC Form 6-K filed by Biotech Acquisition Company6-K - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- SECSEC Form CERT filed by Biotech Acquisition CompanyCERT - Relativity Holdings Inc. (0002072188) (Filer)
- PRInstinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker “BIOT” on July 24, 2026New York, NY, Las Vegas, NV, Tokyo, JP, July 23, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. ("Instinct Bio," "BIOT," or the "Company"), the parent company of Instinct Bio Technical Company Inc, an integrated regenerative medicine and longevity company, and Relativity Acquisition Corp. (OTC:ACQC), a special purpose acquisition company, today jointly announced the successful completion of its previously announced business combination (the "Business Combination"). The milestone positions Instinct Bio into a publicly listed life sciences company and gives U.S. investors direct access to one of the most transformative frontiers in healthcare: the science of living lo
- SECSEC Form 8-A12B filed by Biotech Acquisition Company8-A12B - Relativity Holdings Inc. (0002072188) (Filer)
- SECSEC Form 424B3 filed by Biotech Acquisition Company424B3 - Relativity Holdings Inc. (0002072188) (Filer)
- SECSEC Form EFFECT filed by Biotech Acquisition CompanyEFFECT - Relativity Holdings Inc. (0002072188) (Filer)
- SECSEC Form POS AM filed by Biotech Acquisition CompanyPOS AM - Relativity Holdings Inc. (0002072188) (Filer)
- SECAmendment: SEC Form F-4/A filed by Biotech Acquisition CompanyF-4/A - Relativity Holdings Inc. (0002072188) (Filer)
- SECAmendment: SEC Form F-4/A filed by Biotech Acquisition CompanyF-4/A - Relativity Holdings Inc. (0002072188) (Filer)
- 13D/GSEC Form SC 13G/A filed by Biotech Acquisition Company (Amendment)SC 13G/A - Biotech Acquisition Co (0001825413) (Subject)
- SECSEC Form 15-12G filed by Biotech Acquisition Company15-12G - Biotech Acquisition Co (0001825413) (Filer)
- 13D/GSEC Form SC 13G/A filed by Biotech Acquisition Company (Amendment)SC 13G/A - Biotech Acquisition Co (0001825413) (Subject)
- 13D/GSEC Form SC 13G filed by Biotech Acquisition CompanySC 13G - Biotech Acquisition Co (0001825413) (Subject)
BIOT FAQ
7 questionsWhat does Instinct Bio Technical Company Holdings Inc. do?
INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) is a diversified healthcare and biotechnology company focused on developing and expanding businesses across beauty, wellness, regenerative medicine and related healthcare sectors. Through its operations and strategic partnerships, BIOT seeks to build an integrated platform connecting innovative healthcare technologies, products and services with growth opportunities across Asia and other international markets.What is the latest news on BIOT?
In the last 30 days Quantisnow tracked 2 wire items for BIOT: 1 SEC filing and 1 13D/G filing. The most recent was published on November 10, 2026.Where does BIOT stock trade?
Instinct Bio Technical Company Holdings Inc. (BIOT) is listed on NASDAQ.What sector and industry is BIOT in?
Instinct Bio Technical Company Holdings Inc. operates in the Consumer Discretionary sector, Package Goods/Cosmetics industry.When did Instinct Bio Technical Company Holdings Inc. go public?
Instinct Bio Technical Company Holdings Inc. (BIOT) completed its IPO in 2021.What companies are similar to BIOT?
Notable peers in the same industry include ECL (Ecolab Inc.), KVUE (Kenvue Inc.), UL (Unilever PLC), PG (Procter & Gamble Company), HLN (Haleon plc). Compare BIOT side-by-side with any of them on Quantisnow.How can I track BIOT on Quantisnow?
Quantisnow aggregates Instinct Bio Technical Company Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BIOT to receive live email and push alerts on every new disclosure.